Transcriptomics, proteomics, metabolomics and network pharmacology reveal molecular mechanisms of multi‐targets effects of Shenxianshengmai improving human iPSC‐CMs beating
Open Access
- 6 June 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (6) , e1302
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (82170334, 81870182)
This publication has 7 references indexed in Scilit:
- Clinical evidence-guided network pharmacology analysis reveals a critical contribution of β1-adrenoreceptor upregulation to bradycardia alleviation by Shenxian-ShengmaiBMC Complementary and Alternative Medicine, 2019
- Integrating omics datasets with the OmicsPLS packageBMC Bioinformatics, 2018
- Metabolic profiling of hypoxia/reoxygenation injury in H9c2 cells reveals the accumulation of phytosphingosine and the vital role of Dan-Shen in Xin-Ke-ShuPhytomedicine, 2018
- Molecular Mechanisms of Increased Heart Rate in Shenxianshengmai-treated Bradycardia Rabbits2017
- Evaluation of O2PLS in Omics data integrationBMC Bioinformatics, 2016
- A Systems Oncology Approach Identifies NT5E as a Key Metabolic Regulator in Tumor Cells and Modulator of Platinum SensitivityJournal of Proteome Research, 2015
- O2‐PLS, a two‐block (X–Y) latent variable regression (LVR) method with an integral OSC filterJournal of Chemometrics, 2003